Trinity Biotech (TRIB)
NASDAQ: TRIB
· Real-Time Price · USD
1.05
-0.02 (-1.87%)
At close: Sep 29, 2025, 3:59 PM
1.04
-0.95%
After-hours: Sep 29, 2025, 05:27 PM EDT
-1.87% (1D)
| Bid | 1.03 |
| Market Cap | 10.91M |
| Revenue (ttm) | 61.56M |
| Net Income (ttm) | -31.79M |
| EPS (ttm) | -1.8 |
| PE Ratio (ttm) | -0.58 |
| Forward PE | -0.97 |
| Analyst | n/a |
| Dividends | n/a |
| Ask | 1.06 |
| Volume | 150,111 |
| Avg. Volume (20D) | 4,434,565 |
| Open | 1.07 |
| Previous Close | 1.07 |
| Day's Range | 1.02 - 1.12 |
| 52-Week Range | 0.48 - 3.44 |
| Beta | 0.96 |
| Ex-Dividend Date | n/a |
About TRIB
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol TRIB
Website n/a
Trinity Biotech is scheduled to release its earnings on
Oct 10, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+27.01%
Trinity Biotech shares are trading higher after th...
Unlock content with
Pro Subscription
1 month ago
+89.11%
Trinity Biotech shares are trading higher after the company announced it received regulatory approval to begin FDA-cleared PreClara Preeclampsia Testing service.
